Preclinical Radiation Studies at the MRTC
We have developed a high-throughput mouse-flank irradiation system that delivers the intended dose to flank xenografts. At the same time, our custom shielding blocks 95-99% of the non-targeted animal (with radiation physics QA). We can efficiently irradiate up to 60 mice per hour with flank xenografts.
The large numbers of animals treated allow for robust statistical analysis of tumor kinetics and outcomes when comparing the effects of radiosensitizing agents. Optionally, tissue can be acquired and stored from multiple xenograft samples at various time points during treatment to enable molecular analysis. See our complete list of PDX and cell lines in the GCCRI Xenograft and Cell Lines Core, or provide your own tumor models.
We have designed our system to deliver any clinically relevant dosing schemes that faithfully recapitulate the clinical experience.
To expedite or simplify radiation studies, large fraction sizes are frequently used in radiotherapy, either in vivo or in vitro (5-20 Gy per fraction). This makes preclinical inferences about the effect of drug synergism difficult and potentially meaningless, given that the radiobiology of standard fractionation (1.5-2 Gy per fraction) is starkly different from that of ablative radiation doses (>8 Gy per fraction).
This is especially valuable for preclinical testing of agents intended for patients undergoing standard fractionation (the majority of definitive cases). Using our treatment delivery and recovery protocols, we can deliver 20-30 Gy (2 Gy per fraction), with a subsequent <2% rate of treatment-related animal loss and a prolonged observation period (3-4 months).
Radiation Dosimetry
Lack of rigidity in requirements for NIST (National Institute for Standards and Technology) traceable dosimetry in vitro and in vivo preclinical reporting has resulted in limited reproducibility between reported dose and biological effect among research laboratories. Our dosimetry protocols ensure accurate and precise dose delivery across experiments and improve translational outcomes.
Reproducibility and consistency in reporting radiation findings can vary up to 42% between institutions. Our system has been calibrated by medical radiation physicists with three dosimetry methods to ensure accurate dose delivery to the tissues.
Comprehensive list of diagnoses along with patient demographics:
Genomic information for many samples is available:








